ESRP1 and neoplasm: Multivariate analysis were adjusted for patients age, gender, stage, and microsatellite status, and demonstrated for low compared to mean and high ESRP1 expression in tumor a borderline significance with HR=0.56, 95% CI 0.31-1.01, P=0.055 and HR=0.62, 95% CI 0.36-1.09, P=0.098.